Featuring the debunking of ‘fake news’, cardiovascular clinical trial controversy, open data in the USA, reduced lack of funding for preprint repositories, the wait for the launch of the Projekt DEAL and Wiley flagship journal, ranking and indices in science, and questions surrounding Plan S.
Blog
CBMRT US Biomedical Transparency Summit newsletter
The Center for Biomedical Research Transparency (CBMRT) hosts a free 5-year Biomedical Transparency Summit (BMTS) series in the US and Europe. The goal of BMTS is to promote discussion and collaboration on transparency across the global biomedical research ecosystem
Linking Evidence to Aid researchers in tackling the 2019 novel coronavirus outbreak
As the collection of literature and resources on the 2019 novel coronavirus outbreak increases, Evidence Aid is working to ensure links to the latest research are made discoverable
Weekly digest: what’s happening in open science?
Featuring stakeholder opinions on the proposed White House Executive Order on open access in the USA, a new data-sharing declaration and the introduction of a financial incentive for publishing negative results in Germany
Combatting the next outbreak: why open access matters
As the Open Pharma position statement reaches over 100 endorsements, we share why open access is important for public health and hear why publishing house Frontiers has endorsed the position statement.
Weekly digest: what’s happening in open science?
Featuring a new database of journal policies, the launch of an open peer review trial in Nature, a summary of one patient advocate’s involvement in cancer research and the call from 21 Nobel laureates for an immediate open access mandate
Guest post: Some of the open science challenges faced by authors in Japan
Scientific and medical publishing is becoming more open around the world, including in Japan, where open access and open science are gaining traction.
The evolving role of medical publication professionals in improving the accessibility and discoverability of scientific research
Open Pharma Members, Supporters and key advisers came together to discuss how medical publication professionals can improve the accessibility and discoverability of scientific research.
Weekly digest: what’s happening in open science?
Featuring the role of open science in combating the coronavirus outbreak, a new journal ranking system to measure research transparency and highlights from this week’s ISMPP U webinar.
What does the future look like for medical publications? Insights from ISMPP EU 2020
The 2020 European Meeting of the International Society for Medical Publication Professionals (ISMPP) opened with a question – in one word, “how do you feel about the future of medical publications?” Answers included “exciting”, “evolving” and “digital”.